Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B

Botulinum neurotoxin type B (BoNT/B) recognizes nerve terminals by binding to 2 receptor components: a polysialoganglioside, predominantly GT1b, and synaptotagmin 1/2. It is widely thought that BoNT/B initially binds to GT1b then diffuses in the plane of the membrane to interact with synaptotagmin....

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 116; no. 36; pp. 18098 - 18108
Main Authors: Flores, Alessandra, Ramirez-Franco, Jorge, Desplantes, Richard, Debreux, Kévin, Ferracci, Géraldine, Wernert, Florian, Blanchard, Marie-Pierre, Maulet, Yves, Youssouf, Fahamoe, Sangiardi, Marion, Iborra, Cécile, Popoff, Michel Robert, Seagar, Michael, Fantini, Jacques, Lévêque, Christian, Far, Oussama El
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 03-09-2019
Series:PNAS Plus
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Botulinum neurotoxin type B (BoNT/B) recognizes nerve terminals by binding to 2 receptor components: a polysialoganglioside, predominantly GT1b, and synaptotagmin 1/2. It is widely thought that BoNT/B initially binds to GT1b then diffuses in the plane of the membrane to interact with synaptotagmin. We have addressed the hypothesis that a GT1b–synaptotagmin cis complex forms the BoNT/B receptor. We identified a consensus glycosphingolipid-binding motif in the extracellular juxtamembrane domain of synaptotagmins 1/2 and confirmed by Langmuir monolayer, surface plasmon resonance, and circular dichroism that GT1b interacts with synaptotagmin peptides containing this sequence, inducing α-helical structure. Molecular modeling and tryptophan fluorescence spectroscopy were consistent with the intertwining of GT1b and synaptotagmin, involving cis interactions between the oligosaccharide and ceramide moieties of GT1b and the juxtamembrane and transmembrane domains of synaptotagmin, respectively. Furthermore, a point mutation on synaptotagmin, located outside of the BoNT/B-binding segment, inhibited GT1b binding and blocked GT1b-induced potentiation of BoNT/B binding to synaptotagmin-expressing cells. Our findings are consistent with amodel in which a preassembled GT1b–synaptotagmin complex constitutes the high-affinity BoNT/B receptor.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: M. Seagar, C.L., and O.E.F. designed research; A.F., J.R.-F., R.D., K.D., G.F., F.W., M.-P.B., Y.M., F.Y., M. Sangiardi, C.I., J.F., and C.L. performed research; M.R.P. contributed new reagents/analytic tools; M. Seagar, C.L., and O.E.F. analyzed data; and M. Seagar, J.F., C.L., and O.E.F. wrote the paper.
Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved August 1, 2019 (received for review May 15, 2019)
1A.F. and J.R.-F. contributed equally to this work.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1908051116